propionamide has been researched along with Chronic Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asari, T; Fujimori, Y; Fushimi, N; Inoue, T; Isaji, M; Kobayashi, M; Kurooka, T; Nishibe, H; Onozato, T; Takeda, H; Takemura, M | 1 |
1 other study(ies) available for propionamide and Chronic Disease
| Article | Year |
|---|---|
Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation.
Topics: Amides; Animals; Chronic Disease; Clinical Trials, Phase I as Topic; Constipation; Dietary Fiber; Dogs; Dose-Response Relationship, Drug; Glucosides; Humans; Loperamide; Male; Pyrazoles; Rats; Sodium-Glucose Transporter 1 | 2017 |